Literature DB >> 8642702

Human endogenous retrovirus expression and reverse transcriptase activity in the T47D mammary carcinoma cell line.

C Patience1, G R Simpson, A A Colletta, H M Welch, R A Weiss, M T Boyd.   

Abstract

We have examined the human mammary tumor cell line T47D and have found that these cells produce virus-like particles which band at the typical density for retroviral particles on a sucrose gradient, possess reverse transcriptase activity, and package HERV-K10-like sequences. Using this information and a bacterial expression system to identify long open reading frames, we have identified individual clones which have full-length open reading frames for reverse transcriptase and RNase H and which could encode the reverse transcriptase activity detected in these cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642702      PMCID: PMC190118     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  A novel tumour marker related to the c-myc oncogene product.

Authors:  S Chan; H Gabra; F Hill; G Evan; K Sikora
Journal:  Mol Cell Probes       Date:  1987-03       Impact factor: 2.365

2.  Detection of retrovirus in patients with myeloproliferative disease.

Authors:  M T Boyd; N Maclean; D G Oscier
Journal:  Lancet       Date:  1989-04-15       Impact factor: 79.321

3.  Studies on the presence of particles resembling RNA virus particles in human breast tumors, pleural effusions, their tissue cultures, and milk.

Authors:  G Seman; H S Gallager; J M Lukeman; L Dmochowski
Journal:  Cancer       Date:  1971-12       Impact factor: 6.860

4.  Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D.

Authors:  M Ono; M Kawakami; H Ushikubo
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

5.  Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome.

Authors:  M Ono; T Yasunaga; T Miyata; H Ushikubo
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

6.  Expression of human endogenous retroviral sequences in peripheral blood mononuclear cells of healthy individuals.

Authors:  P Medstrand; M Lindeskog; J Blomberg
Journal:  J Gen Virol       Date:  1992-09       Impact factor: 3.891

7.  Production of virus by embryonic cultures co-cultivated with breast tumour cells or infected with milk from breast cancer patients.

Authors:  J Keydar; Z Gilead; S Karby; E Harel
Journal:  Nat New Biol       Date:  1973-01-10

8.  Properties of retrovirus-like particles produced by a human breast carcinoma cell line: immunological relationship with mouse mammary tumor virus proteins.

Authors:  I Keydar; T Ohno; R Nayak; R Sweet; F Simoni; F Weiss; S Karby; R Mesa-Tejada; S Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

9.  An in vivo assay for the reverse transcriptase of human retrotransposon L1 in Saccharomyces cerevisiae.

Authors:  B A Dombroski; Q Feng; S L Mathias; D M Sassaman; A F Scott; H H Kazazian; J D Boeke
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

10.  THE MILK-INFLUENCE OF BREAST TUMORS IN MICE.

Authors:  J J Bittner
Journal:  Science       Date:  1942-05-01       Impact factor: 47.728

View more
  16 in total

1.  Expression of Human Endogenous Retrovirus Type K Envelope Protein is a Novel Candidate Prognostic Marker for Human Breast Cancer.

Authors:  Jing Zhao; Kiera Rycaj; Shanshan Geng; Ming Li; Joshua B Plummer; Bingnan Yin; Hong Liu; Xu Xu; Yinchun Zhang; Yanfang Yan; Sharon A Glynn; Tiffany H Dorsey; Stefan Ambs; Gary L Johanning; Lin Gu; Feng Wang-Johanning
Journal:  Genes Cancer       Date:  2011-09

2.  Proviral structure, chromosomal location, and expression of HERV-K-T47D, a novel human endogenous retrovirus derived from T47D particles.

Authors:  W Seifarth; C Baust; A Murr; H Skladny; F Krieg-Schneider; J Blusch; T Werner; R Hehlmann; C Leib-Mösch
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

3.  Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus.

Authors:  B Berkhout; M Jebbink; J Zsíros
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

4.  Activation of the long terminal repeat of human endogenous retrovirus K by melanoma-specific transcription factor MITF-M.

Authors:  Iyoko Katoh; Anna Mírová; Shun-ichi Kurata; Yasushi Murakami; Kenji Horikawa; Natsuko Nakakuki; Takunobu Sakai; Kunihiko Hashimoto; Ayako Maruyama; Takaaki Yonaga; Nahoko Fukunishi; Kohji Moriishi; Hirohisa Hirai
Journal:  Neoplasia       Date:  2011-11       Impact factor: 5.715

5.  A novel exogenous retrovirus sequence identified in humans.

Authors:  D J Griffiths; P J Venables; R A Weiss; M T Boyd
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells.

Authors:  C Patience; Y Takeuchi; F L Cosset; R A Weiss
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  Mouse mammary tumor virus superantigen expression in B cells is regulated by a central enhancer within the pol gene.

Authors:  F U Reuss; J M Coffin
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 8.  Human endogenous retroviruses: transposable elements with potential?

Authors:  P N Nelson; P Hooley; D Roden; H Davari Ejtehadi; P Rylance; P Warren; J Martin; P G Murray
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

9.  Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker.

Authors:  Maya Golan; Amnon Hizi; James H Resau; Neora Yaal-Hahoshen; Hadar Reichman; Iafa Keydar; Ilan Tsarfaty
Journal:  Neoplasia       Date:  2008-06       Impact factor: 5.715

Review 10.  Demystified. Human endogenous retroviruses.

Authors:  P N Nelson; P R Carnegie; J Martin; H Davari Ejtehadi; P Hooley; D Roden; S Rowland-Jones; P Warren; J Astley; P G Murray
Journal:  Mol Pathol       Date:  2003-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.